Related by context. Frequent words. (Click for all words.) 68 anticancer compound 64 Tesetaxel 63 topical anti infective 63 antisense drug 63 Onalta 62 Panzem R 62 Dapagliflozin 62 deforolimus 62 sodium Injection 62 HCV protease inhibitor 62 Neo Urinary Conduit 61 multi kinase inhibitor 61 liposomal formulation 61 JAK1 61 R sorafenib tablets 61 orally bioavailable 61 MKC# 61 AEG# 60 Nexavar ® 60 optical biosensors 60 fibrosis IPF 60 proteasome inhibitor 60 Mipomersen 60 Daclizumab 60 MEK inhibitor 59 phase IIb clinical 59 active cellular immunotherapy 59 Chemokine Therapeutics 59 Factor VIIa 59 Nanobody 59 Amrubicin 59 Ambrisentan 58 novel orally administered 58 BrachySil 58 Picoplatin 58 injectable formulation 58 Proxinium TM 58 humanized monoclonal antibody 58 drug eluting coronary stent 58 Pivotal Phase III 58 Pivotal Phase 58 pseudobulbar affect PBA 58 vosaroxin 58 Thiarabine 58 ALN TTR# 58 cancer immunotherapies 57 refractory chronic lymphocytic 57 ATL# [001] 57 Completes Enrollment 57 dalbavancin 57 Phase 2a clinical 57 CCX# 57 humanized anti 57 TLR9 agonist 57 Azedra 57 IND submission 57 Phase III Clinical Trial 57 targeting CD# 57 nitric oxide donating 57 GVAX R 57 addressing idiopathic pulmonary 56 Aurexis 56 Altropane 56 Initiates Phase 56 Zolinza 56 immunotherapeutic 56 Icatibant 56 oncology therapeutics 56 investigational compounds 56 phenylketonuria PKU developed 56 MVA BN R 56 polymerase inhibitor 56 Idera Pharmaceuticals 56 IND Investigational New 56 Hsp# inhibitor 56 MNTX 56 vascular disrupting agent 56 investigational oral 56 BEMA TM Fentanyl 56 Initiate Phase 56 Ixempra 56 Naproxcinod 56 submitted Biologics License 56 rNAPc2 56 pramlintide acetate injection 56 HGS ETR1 56 ThermoDox R 56 Loramyc R 56 StemEx 56 Perifosine 56 Regado 56 OncoVEX GM CSF 56 subcutaneous formulation 56 anti TNF alpha 55 mTOR inhibitor 55 Phase IIa trial 55 BiTE antibody 55 Carfilzomib 55 MGCD# [001] 55 phase IIa clinical 55 orally administered